Efficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Weisinger J, Bouzid R, Fadlallah J, Barbet C, Provot F, Poullin P, Neel A, Marie M, Rieu V, Kanouni T, Moranne O, Azoulay E, Marjanovic Z, Corre E, Joly AC, Baylatry MT, Joly BS, Veyradier A, Coppo P; French National Center for Thrombotic Microangiopathies (CNR‐MAT).
Weisinger J, et al. Among authors: azoulay e.
Am J Hematol. 2024 Dec 12. doi: 10.1002/ajh.27550. Online ahead of print.
Am J Hematol. 2024.
PMID: 39668454
No abstract available.